Healing Reimagined
Immunicom’s Immunopheresis® is designed to empower
patients to best live their lives while receiving revolutionary
cancer treatment.This unique immunotherapy is intended
to meaningfully improve patients’ quality of life and
avoid typical side-effects.
LATEST MILESTONE
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe
A transformative immunotherapy
Immunicom creates novel immunotherapies designed to treat a variety of diseases using Immunicom’s breakthrough Immunopheresis® technology platform.
The breakthrough Immunopheresis approach uses a therapeutic device that works outside of the body and is designed to treat cancer, inflammatory, renal, and autoimmune diseases by removing barriers from the blood that block the immune system from doing its job.
Our Recognition
Designed to treat
multiple diseases
multiple diseases
Worldwide clinical trials are underway at leading hospitals to evaluate Immunopheresis in several cancer types, both as a singular therapy and in combination with other treatments.
Latest News
December 3, 2021
Journal for Immunotherapy of Cancer
November 16, 2021
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe
November 2, 2021
Immunicom Conference Highlights Innovation in Clinical Trial Design to Advance its Breakthrough Cancer Immunotherapy Platform
October 7, 2021
Immunicom Hires Former FDA Clinician and Medical Device Reviewer to Rapidly Progress Launch of Novel Cancer Immunotherapy
Our Mission
To improve the quality of life for patients
in a meaningful way and expedite their
path to a healthy future.
Get in touch today
Let’s talk about what we can achieve together
Learn more about
our team
our team